RE:RE:RE:RE:RE:RE:What did we learn here?Tumor growth inhibition, in other words, slowing down growth speed, is not even stable disease on an animal model, so not close to tumor shrinkage. I understand that these CSCs are very resistant, but this is relatively minor result. It adds a thin layer of knowledge to the whole thing on animal models and genetically homogenous tumors, but it really does not mean much for real human patients.
For me the main thing I take from this PR, is that they were willing to publish it at this stage. Maybe I don't understand how it works in reality, but it seems to me that I would not publish positive results on animals if I would not already have some efficacy data in the phase Ib. If they have these efficacy signs in phase Ib, then it makes a lot of sense to publish this press release today. It's a way to send a signal that everything is on track. That's the way I see it, but again, it's only me.